Advertisement

Latest News

Current Gaps in Psoriasis Care: Tolerability, Efficacy, and Rate of Response

1 hour ago

The panel explores patient attitudes toward oral vs injectable treatments and practical limitations of current oral agents.

Managing Pediatric AD With New Topicals

1 hour ago

Panelists discuss how new nonsteroidal therapies improve adherence, comfort, and long-term skin health for children with AD.

Understanding PCSK9 and Its Role in ASCVD Management

1 hour ago

Explore the mechanisms and differences between PCSK9 inhibitors, including monoclonal antibodies and siRNA, in lowering LDL cholesterol effectively.

Ruxolitinib Efficacy and Safety in Pediatric AD

1 hour ago

Panelists discuss how JAK-targeting topical therapies offer effective, well-tolerated solutions for children with mild to moderate AD.

An Overview of Treat-to-Target in Psoriasis

1 hour ago

Review of the updated IPC framework defining topical failure, reducing “topical churn,” and guiding earlier systemic escalation.

Advertisement
Advertisement